| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |